research finding

Rochester researchers have created particles with negative mass in an atomically thin semiconductor, using a device that creates an optical microcavity.

Each year, the University of Rochester produces academic and scholarly work that contributes to our understanding and appreciation of the world around us.

Professor Robert Doran focuses on iconic 20th-century philosophers like Michel Foucault, Hayden White, Gayatri Spivak, and Richard Rorty, and explores critical theory's pivot away from a narrowly focused investigation of meaning and text.

Just before dawn on May 18, 1683, pirates stormed the port city of Veracruz, capturing around 1,500 people and selling them to the slave markets of Haiti and South Carolina. Pablo Sierra Silva, assistant professor of history, is on a mission to trace what happened to them.

For more than 30 years, researchers have been creating quantum dots—nanoscale semiconductors with remarkable properties. But quantum dot synthesis has occurred largely by trial and error. Thanks to the work of two Rochester chemists, that may be about to change.

How did water vapor became integral to the development and design of a novel device for detecting the DNA biomarkers affiliated with disease?

In a series of experiments, Rochester psychologists found that people who sat alone without devices for 15 minutes and chose what to think about experienced the positive effects of solitude: feeling calmer and less anxious, without feeling lonely or sad.

Scientists at the HAWC Gamma Ray Observatory have ruled out two pulsars as the source of an unexpectedly large presence of positrons in our corner of the galaxy. Could they come from something more complex and exotic: dark matter?

Using the strange rules of quantum mechanics, researchers were able to put a quantum bit in a superposition of two different energy states at the same time in order to speed up the accurate measurement of frequencies.

A pathway that enables embryonic cells to develop into different organs can be reactivated by cancer cells. A cyclic peptide has been found that can block the activation of this pathway, and is also less likely to trigger resistance in cancer cells.